Titre : | EMCDDA initial report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene). In accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended) |
Auteurs : | OEDT = EMCDDA |
Type de document : | Rapport |
Editeur : | Lisbon : OEDT / EMCDDA, 2020 |
Autre Editeur : | Luxembourg : Publications Office of the European Union |
Collection : | Initial reports, ISSN 2600-0954 |
ISBN/ISSN/EAN : | 978-92-9497-491-4 |
Format : | 22 p. |
Langues: | Anglais |
Discipline : | PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods) |
Mots-clés : |
Organismes OEDTThésaurus géographique EUROPE ; UNION EUROPEENNEThésaurus mots-clés OPIOIDES ; DROGUES DE SYNTHESE ; LEGISLATION ; ANALGESIQUES ; SURVEILLANCE EPIDEMIOLOGIQUE ; FACTEUR DE RISQUE ; CHIMIE ; PHARMACOLOGIE ; SAISIE ; TOXICOLOGIE |
Résumé : | Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial report has been prepared and submitted to the Commission and the Member States, in accordance with Article 5b of Regulation (EC) No 1920/2006 (as amended). Its purpose is to provide scientific evidence to the Commission to allow it to make an informed decision regarding whether or not there is a need to request a risk assessment on a new psychoactive substance. |
Domaine : | Autres substances / Other substances |
Lien : | https://www.emcdda.europa.eu/publications/initial-reports/isotonitazene |
Titre suivant : |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Documents numériques (1)
EMCDDA_Initial-report_Isotonitazene_2020.pdf Adobe Acrobat PDF |
Accueil